ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AGRX Agile Therapeutics Inc

0.6022
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Agile Therapeutics Inc NASDAQ:AGRX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.6022 0.27 0.2994 0 01:00:00

Agile Therapeutics to Participate in Virtual Fireside Chat as Part of the 2021 RBC Capital Markets Global Healthcare Conferen...

12/05/2021 1:00pm

GlobeNewswire Inc.


Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart


From May 2021 to May 2024

Click Here for more Agile Therapeutics Charts.

Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that Al Altomari, Chairman and Chief Executive Officer, will participate in a virtual fireside chat as part of the 2021 RBC Capital Markets Global Healthcare Conference on Wednesday, May 19, 2021 at 1:20 p.m. ET.

The fireside chat will be webcast live and can be accessed in the Events and Presentations section of the Investor Relations page at https://ir.agiletherapeutics.com/events-and-presentations/, or by clicking here: https://event.on24.com/wcc/r/3173531/F391B23E756682EFEFE4952267784F45

The webcast will be archived on the Agile Therapeutics website for 30 days following the event.

About Agile Therapeutics, Inc.

Agile Therapeutics is a forward-looking women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla®, (levonorgestrel and ethinyl estradiol), a transdermal system, is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website.

Contact: Matt RileyHead of Investor Relations & Corporate Communicationsmriley@agiletherapeutics.com

1 Year Agile Therapeutics Chart

1 Year Agile Therapeutics Chart

1 Month Agile Therapeutics Chart

1 Month Agile Therapeutics Chart

Your Recent History

Delayed Upgrade Clock